1. Academic Validation
  2. Packaged release and targeted delivery of cytokines by migrasomes in circulation

Packaged release and targeted delivery of cytokines by migrasomes in circulation

  • Cell Discov. 2024 Dec 9;10(1):121. doi: 10.1038/s41421-024-00749-x.
Haifeng Jiao 1 Xiaopeng Li 1 Ying Li 1 Ziyi Guo 2 Yuzhuo Yang 2 Yiqun Luo 1 Xiaoyu Hu 2 Li Yu 3
Affiliations

Affiliations

  • 1 State Key Laboratory of Membrane Biology, Tsinghua University-Peking University Joint Centre for Life Sciences, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing, China.
  • 2 Institute for Immunology, Tsinghua University-Peking University Joint Centre for Life Sciences, School of Medicine, Tsinghua University, Beijing, China.
  • 3 State Key Laboratory of Membrane Biology, Tsinghua University-Peking University Joint Centre for Life Sciences, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing, China. liyulab@mail.tsinghua.edu.cn.
Abstract

In dynamic systems like the circulatory system, establishing localized cytokine gradients is challenging. Upon lipopolysaccharide (LPS) stimulation, we observed that monocytes release numerous migrasomes enriched with inflammatory cytokines, such as TNF-α and IL-6. These cytokines are transported into migrasomes via secretory carriers, leading to their immediate exocytosis or eventual release from detached migrasomes. We successfully isolated TNF-α and IL-6-enriched, monocyte-derived migrasomes from the blood of LPS-treated mice. Total secretion analysis revealed a substantial amount of TNF-α and IL-6 released in a migrasome-packaged form. Thus, detached, monocyte-derived migrasomes represent a type of extracellular vesicle highly enriched with cytokines. Physiologically, these cytokine-laden migrasomes rapidly accumulate at local sites of inflammation, effectively creating a concentrated source of cytokines. Our research uncovers novel mechanisms for cytokine release and delivery, providing new insights into immune response modulation.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-100506
    99.43%, Integrin Receptor Antagonist
  • HY-120852
    98.01%, ADAM17 Inhibitor
    MMP